

When you join the UMass Chan Medical School team, you join us in advancing together to improve the health and well-being of our diverse communities throughout Massachusetts and across the US and the world. Together, we lead in education, research, health care delivery, and public service. Your life’s work is more than a career. It’s an expression of your passion, intellect, skill, and drive. UMass Chan's commitment to excellence, innovation, competitive benefits, and work-life integration will allow you to build a professionally rewarding career as we work together to better or improve the health of people around the globe.
BRIDGE Innovation & Business Development, at University of Massachusetts Chan Medical School (UMass Chan) is looking for a Manager/Sr. Manager-Contracts to join their team.
What do we do? BRIDGE team ideates and executes a comprehensive business strategy to commercialize UMass Chans IP portfolio through the development of New Companies (NewCos), alliances, licensing agreements and partnerships. BRIDGE team is accountable for structuring, negotiating, and implementing a variety of transactions with external entities, including investors, leading as well as new pharma/biotech companies, incubators, and other research organizations.
Success at BRIDGE & UMass Chan: BRIDGE @ UMass Chan reported licensing revenue of approximately $146 million during FY2018 and ranked fourth among all U.S. institutions and third among universities in terms of licensing revenue. BRIDGE and UMass Chan researchers have also co-founded multiple successful companies – Alnylam, Atalanta Therapeutics, ApicBio, Voyager Therapeutics, Generation Bio, Acworth & Bacainn to name a few.
UMass Chan is a research powerhouse: UMass Chan is a vibrant research enterprise that spends >$250M per year in research activities and consistently produces noteworthy advances in clinical and basic research. In 2006, the Nobel Prize in Physiology or Medicine was awarded to UMass Chan professor Craig C. Mello, PhD for discoveries related to RNA interference (RNAi). In 2024 the Nobel Prize in Physiology or Medicine was awarded to Victor Ambros for the discovery of microRNA and its role in post-transcriptional gene regulation. UMass Chan researchers have made pivotal advances in HIV, cancer, diabetes, infectious disease, and in understanding the molecular basis of disease. UMass Chan programs and centers include the RNA Therapeutics Institute, the Gene Therapy Center, Program in Gene Function and Expression, Systems Biology and Neurotherapeutics.
POSITION SUMMARY:
The Manager/Sr. Manager will serve as support for Office of Innovation & Business Development - Transactions leadership.
ESSENTIAL FUNCTIONS:
REQUIRED QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
Paralegal or degree in scientific field with additional experience in academic or public sector.
#LI-ATI
Posting Disclaimer:
This job posting outlines the primary responsibilities and qualifications for the role but is not intended to be an exhaustive list.
Duties and expectations may evolve in response to the needs of the department and the broader institution.
In alignment with our commitment to pay transparency, the base salary range for this position is listed above (exclusive of benefits and retirement).
At UMass Chan Medical School, final base salary offers are determined based on a combination of factors, including your skills, education, and relevant experience.
We also consider internal equity to ensure fair and consistent compensation across our teams.
Please note that the range provided reflects the full base salary range for this position. Offers are typically made within the midrange to allow for future growth and development within the role.
In addition to base pay, UMass Chan offers a comprehensive Total Rewards package, which includes paid time off, medical, dental, and vision coverage, and participation in a 401(a)-retirement plan, with the option to contribute to a voluntary 403(b) plan.
UMass Chan welcomes all qualified applicants and complies with all state and federal anti-discrimination laws.